| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/26/2014 | CN102657597B Biodegradable super-molecular hydrogel loaded with antitumor medicament and preparation method thereof |
| 02/26/2014 | CN102641245B Chitosan-chitosan derivative nanosphere for loading indissoluble medicament, preparation method of nanosphere, and application of nanosphere serving as oral prepration |
| 02/26/2014 | CN102634307B Hot-melting pressure sensitive adhesive and preparation method thereof |
| 02/26/2014 | CN102626395B Solid preparation of aliskiren-valsartan pharmaceutical composition liposome |
| 02/26/2014 | CN102585151B Polyurethane segmented copolymer containing disulfide bonds and tertiary amine groups as well as preparation method of polyurethane segmented copolymer |
| 02/26/2014 | CN102585064B Porous and magnetic anisotropy microspheres and preparation method thereof |
| 02/26/2014 | CN102579344B Losartan potassium liposome solid preparation |
| 02/26/2014 | CN102481286B Antimycotic pharmaceutical composition |
| 02/26/2014 | CN102470131B Fentanyl-containing adhesive preparation for external use |
| 02/26/2014 | CN102458368B Solid pharmaceutical preparations containing copolymers based on polyethers combined with poorly water-soluble polymers |
| 02/26/2014 | CN102432695B Preparation method of N-2-hydroxypropyl trimethyl ammonium chloride chitosan carried Newcastle disease attenuated live vaccine-loaded nanoparticles |
| 02/26/2014 | CN102357084B Enalapril maleate tablet composition and its preparation and use |
| 02/26/2014 | CN102335134B Clevidipine butyrate liquid liposome preparation |
| 02/26/2014 | CN102325823B Synthesis of obtaining modified polyethylene glycol intermediates |
| 02/26/2014 | CN101677959B Slow release pharmaceutical composition made of microparticles |
| 02/26/2014 | CN101636148B Linker-based lecithin microemulsion delivery vehicles |
| 02/26/2014 | CN101528264B Controlled release of phenolic opioids |
| 02/26/2014 | CN101455649B Disposal systems of transdermal delivery devices to prevent misuse of the active agents contained therein |
| 02/25/2014 | US8658703 Aqueous suspension preparations |
| 02/25/2014 | US8658695 Disodium salts, monohydrates, and ethanol solvates for delivering active agents |
| 02/25/2014 | US8658626 Controlled release corticosteroid compositions and methods for the treatment of otic disorders |
| 02/25/2014 | US8658607 Immunostimulatory G, U-containing oligoribonucleotides |
| 02/25/2014 | US8658601 Peptides and nanoparticles for therapeutic and diagnostic applications |
| 02/25/2014 | US8658597 Stabilised compositions of factor VII polypeptides |
| 02/25/2014 | US8658593 Treatment of extracellular matrix to reduce inflammation |
| 02/25/2014 | US8658433 Dye compounds as photoactive agents |
| 02/25/2014 | US8658348 Spatially-defined modification of fresh tissue using covalent chemistry |
| 02/25/2014 | US8658215 Injectable microspheres for dermal augmentation and tissue bulking |
| 02/25/2014 | US8658212 Pharmaceutical composition containing fenofibrate and method for the preparation thereof |
| 02/25/2014 | US8658205 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend |
| 02/25/2014 | US8658204 Transpulmonary liposome for controlling drug arrival |
| 02/25/2014 | US8658192 Integrated antimicrobial and low fouling materials |
| 02/25/2014 | US8658183 Antimicrobial parenteral formulation |
| 02/25/2014 | US8658168 Compositions and methods for homoconjugates of antibodies which induce growth arrest of apoptosis of tumor cells |
| 02/25/2014 | CA2788707C Compositions and methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells |
| 02/25/2014 | CA2747954C Phosphonate compounds |
| 02/25/2014 | CA2636217C Irradiated compositions and treatment of cancers with radiation in combination with taurolidine and/or taurultam |
| 02/25/2014 | CA2476589C Compositions for delivery of therapeutics and other materials, and methods of making and using the same |
| 02/25/2014 | CA2471879C Pharmaceutical composition containing ghrelin |
| 02/25/2014 | CA2207252C Inhibitors of prenyl transferases |
| 02/20/2014 | WO2014028941A2 Adipose composition systems and methods |
| 02/20/2014 | WO2014028608A1 Method of treating skin disorders using nanoscale delivery devices and transdermal enhancing compositions |
| 02/20/2014 | WO2014028560A2 T-cell redirecting bispecific antibodies for treatment of disease |
| 02/20/2014 | WO2014028487A1 Amine-containing lipidoids and uses thereof |
| 02/20/2014 | WO2014028087A1 Liposomal formulations of polymyxin and uses thereof |
| 02/20/2014 | WO2014028057A1 Prostate specific antigen agents and methods of using same for prostate cancer imaging |
| 02/20/2014 | WO2014027996A1 Improved methods for treating cancer with reduced renal toxicity |
| 02/20/2014 | WO2014027994A1 Methods for treatment of cancer using lipoplatin |
| 02/20/2014 | WO2014027973A1 Paliperidone oral solution |
| 02/20/2014 | WO2014027302A1 Glycoconjugation processes and compositions |
| 02/20/2014 | WO2014027006A1 Bioadhesive formulations for use in drug delivery |
| 02/20/2014 | WO2014026954A1 Liquid factor viii formulations |
| 02/20/2014 | WO2014026656A1 Nanofiber structure with immobilized organic agens and the method of its preparation |
| 02/20/2014 | WO2014026502A1 Use of chrysalis oil for improving bioavailability of small molecule drug |
| 02/20/2014 | WO2014026435A1 Preparation method of targeted graphene nano-drug carrier |
| 02/20/2014 | WO2014026286A1 Conjugates including an antibody moiety, a polypeptide that traverses the blood-brain barrier, and a cytotoxin |
| 02/20/2014 | WO2014026284A1 Internal structured self assembling liposomes |
| 02/20/2014 | WO2014026283A1 Peptide-dendrimer conjugates and uses thereof |
| 02/20/2014 | WO2014026213A1 Antiseptic composition |
| 02/20/2014 | WO2013177419A3 Lipid nanoparticle compositions and methods of making and methods of using the same |
| 02/20/2014 | WO2013177062A3 Methods for improving safety of blood-brain barrier transport |
| 02/20/2014 | WO2013126990A8 Method for the preparation of triglycerides of medium-chain length fatty acids |
| 02/20/2014 | WO2012156820A9 Intranasal testosterone bio-adhesive gel formulations and use thereof for treating male hypogonadism |
| 02/20/2014 | US20140051845 Method Involving 1-Benzotriazolyl Carbonate Esters of Poly(ethylene glycol) |
| 02/20/2014 | US20140051770 Injectable multimodal polymer depot compositions and uses thereof |
| 02/20/2014 | US20140051733 Febuxostat pharmaceutical compositions |
| 02/20/2014 | US20140051671 Pharmaceutical compositions |
| 02/20/2014 | US20140051663 Glycerophospholipids for the improvement of cognitive functions |
| 02/20/2014 | US20140051646 Cell penetrating peptides |
| 02/20/2014 | US20140051635 Combination therapy for treatment of cancer |
| 02/20/2014 | US20140051623 Bisphosphonate-Prodrugs |
| 02/20/2014 | US20140051166 Method and medicament for inhibiting the expression of a given gene |
| 02/20/2014 | US20140051145 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| 02/20/2014 | US20140050799 Risperidone sustained release microsphere composition |
| 02/20/2014 | US20140050790 Triterpene-containing oleogel-forming agent, triterpene-containing oleogel and method for producing a triterpene-containing oleogel |
| 02/20/2014 | US20140050785 Dissolution properties of drug products containing olmesartan medoxomil |
| 02/20/2014 | US20140050767 Epidermal cooling |
| 02/20/2014 | US20140050746 Auristatin drug linker conjugates |
| 02/20/2014 | US20140050745 Melanocortin Receptor Binding Conjugates |
| 02/20/2014 | US20140050744 Compositions and methods for the diagnosis and treatment of tumor |
| 02/20/2014 | US20140050718 Methods and Compositions for Enhancing Intranasal Delivery of Therapeutic Agents |
| 02/20/2014 | US20140050690 Nanoparticle containing prostaglandin i 2 derivative |
| 02/20/2014 | US20140050660 T-Cell Redirecting Bispecific Antibodies for Treatment of Disease |
| 02/20/2014 | CA2874864A1 T-cell redirecting bispecific antibodies for treatment of disease |
| 02/19/2014 | EP2698168A1 Paliperidone Oral Solution |
| 02/19/2014 | EP2698159A1 Pitavastatin-containing preparation and method for producing same |
| 02/19/2014 | EP2698144A1 Prolonged release gabapentin tablet formulation whose ability to stay in the stomach is improved |
| 02/19/2014 | EP2697288A1 Decorated macromolecular scaffolds |
| 02/19/2014 | EP2697247A1 Method for the rapid chemoenzymatic glycosylation of conjugates between peptides and hydrophilic polymers |
| 02/19/2014 | EP2696899A1 Polymer conjugated prostaglandin analogues |
| 02/19/2014 | EP2696898A2 Compositions comprising saccharide binding moieties and methods for targeted therapy |
| 02/19/2014 | EP2696897A2 Albumin binding probes and drug conjugates thereof |
| 02/19/2014 | EP2696896A1 System for purifying, producing and storing biomolecules |
| 02/19/2014 | EP2696887A2 Redox responsive polymeric nanocapsules for protein delivery |
| 02/19/2014 | EP2696876A1 Aqueous ophthalmic composition |
| 02/19/2014 | EP2696855A1 Coated mesoporous nanoparticles |
| 02/19/2014 | EP2696854A1 Febuxostat solid dispersion |
| 02/19/2014 | EP2696853A1 Surface induced disassembly of nano containers |
| 02/19/2014 | EP2696847A1 Fatty acid acylated amino acids for oral peptide delivery |
| 02/19/2014 | EP2696705A1 Encapsulation system for protection of probiotics during processing |